Predictors of 1-year survival assessed at the time of bone marrow transplantation

被引：28

作者：

Chang, G

Orav, EJ

Tong, MY

Antin, JH

机构：

[1] Brigham & Womens Hosp, Boston, MA 02115 USA

[2] Harvard Univ, Sch Med, Dept Psychiat, Boston, MA 02115 USA

[3] Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA

[4] Harvard Univ, Sch Med, Dept Med Biostat, Boston, MA 02115 USA

[5] Dana Farber Canc Inst, Boston, MA 02115 USA

来源：

PSYCHOSOMATICS | 2004年 / 45卷 / 05期

关键词：

D O I：

10.1176/appi.psy.45.5.378

中图分类号：

R749 [精神病学];

学科分类号：

100205 ;

摘要：

The purpose of this prospective cohort study was to identify pretransplant and transplant predictors of 1-year survival after allogeneic hematopoietic stem cell transplantation (HSCT) for chronic myelogenous leukemia. Psychosocial and behavioral variables such as alcohol abuse and cigarette smoking were systematically assessed at the time of HSCT with structured diagnostic instruments. A total of 114 patients participated, with an overall 1-year survival rate of 66%. Lifetime alcohol and other substance use, cigarette smoking, depression, and quality of life prior to transplant were not found to affect 1-year survival. However, other clinical variables prior to transplant and once transplant occurred were found to predict survival.

引用

收藏

页码：378 / 385

页数：8

相关论文

共 46 条

[11] Liver transplantation in patients with alcohol and other substance use disorders [J].

DiMartini, A ;

Weinreb, R ;

Fireman, M .

PSYCHIATRIC CLINICS OF NORTH AMERICA, 2002, 25 (01) :195-+

[12] Cancers weakly related to smoking [J].

Doll, R .

BRITISH MEDICAL BULLETIN, 1996, 52 (01) :35-49

[13] Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the philadelphia chromosome. [J].

Druker, BJ ;

Sawyers, CL ;

Kantarjian, H ;

Resta, DJ ;

Reese, SF ;

Ford, JM ;

Capdeville, R ;

Talpaz, M .

NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (14) :1038-1042

[14] Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia. [J].

Druker, BJ ;

Talpaz, M ;

Resta, DJ ;

Peng, B ;

Buchdunger, E ;

Ford, JM ;

Lydon, NB ;

Kantarjian, H ;

Capdeville, R ;

Ohno-Jones, S ;

Sawyers, CL .

NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (14) :1031-1037

[15]

Enright H, 1996, BONE MARROW TRANSPL, V17, P537

[16]

Ferguson ME, 1997, CLIN TRANSPLANT, V11, P49

[17]

First M.B., 2002, Structured Clinical Interview for DSM-IV-TR Axis I Disorders, Research Version, Patient Edition (SCID-I/P)

[18] Fate of chronic myeloid leukemia patients treated with allogeneic bone marrow transplantation or chemotherapy and/or interferon at a single center: long-term results [J].

Gaziev, D ;

Galimberti, M ;

Polchi, P ;

Angelucci, E ;

Giardini, C ;

Baronciani, D ;

Andreani, M ;

Persini, B ;

Erer, B ;

Sodani, P ;

Manna, M ;

Nicolini, G ;

Visani, G ;

Lucarelli, G .

BONE MARROW TRANSPLANTATION, 2002, 29 (01) :1-8

[19] Targeting the BCR-ABL tyrosine kinase in chronic myeloid leukemia. [J].

Goldman, JM ;

Melo, JV .

NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (14) :1084-1086

[20] Bone marrow transplants from unrelated donors for patients with chronic myeloid leukemia [J].

Hansen, JA ;

Gooley, TA ;

Martin, PJ ;

Appelbaum, F ;

Chauncey, TR ;

Clift, RA ;

Petersdorf, EW ;

Radich, J ;

Sanders, JE ;

Storb, RF ;

Sullivan, KM ;

Anasetti, C .

NEW ENGLAND JOURNAL OF MEDICINE, 1998, 338 (14) :962-968

← 1 2 3 4 5 →